tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl) has been researched along with u 69593 in 1 studies
Studies (tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl)) | Trials (tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl)) | Recent Studies (post-2010) (tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl)) | Studies (u 69593) | Trials (u 69593) | Recent Studies (post-2010) (u 69593) |
---|---|---|---|---|---|
15 | 0 | 0 | 524 | 0 | 75 |
Protein | Taxonomy | tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl) (IC50) | u 69593 (IC50) |
---|---|---|---|
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0006 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.194 | |
Delta-type opioid receptor | Homo sapiens (human) | 3.6437 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0021 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.058 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.588 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desmeules, JA; Guilbaud, G; Kayser, V | 1 |
1 other study(ies) available for tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl) and u 69593
Article | Year |
---|---|
Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain.
Topics: Analgesics; Animals; Benzeneacetamides; Benzomorphans; Disease Models, Animal; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vocalization, Animal | 1993 |